BNP Paribas Financial Markets
ZLAB icon

BNP Paribas Financial Markets’s Zai Lab ZLAB Stock Holding History

BNP Paribas Financial Markets’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Buy
768
+15
+2% +$296 ﹤0.01% 5323
2026
Q1 		$14.2K Sell
753
-131
-15% -$2.43K ﹤0.01% 5157
2025
Q4 		$15.6K Buy
884
+87
+11% +$2.04K ﹤0.01% 5077
2025
Q3 		$27K Sell
797
-83,229
-99% -$2.87M ﹤0.01% 4829
2025
Q2 		$2.94M Buy
84,026
+83,188
+9,927% +$2.74M ﹤0.01% 2204
2025
Q1 		$30.3K Sell
838
-18,917
-96% -$582K ﹤0.01% 4432
2024
Q4 		$517K Buy
19,755
+18,472
+1,440% +$513K ﹤0.01% 3282
2024
Q3 		$31K Sell
1,283
-5,313
-81% -$100K ﹤0.01% 3696
2024
Q2 		$114K Buy
6,596
+3,925
+147% +$69K ﹤0.01% 3257
2024
Q1 		$42.8K Buy
2,671
+904
+51% +$19K ﹤0.01% 3586
2023
Q4 		$48.3K Buy
1,767
+548
+45% +$14.5K ﹤0.01% 3572
2023
Q3 		$29.6K Sell
1,219
-826
-40% -$22K ﹤0.01% 3527
2023
Q2 		$56.7K Sell
2,045
-155,751
-99% -$5.09M ﹤0.01% 3430
2023
Q1 		$5.25M Buy
157,796
+23,913
+18% +$918K 0.01% 1221
2022
Q4 		$4.11M Buy
133,883
+24,290
+22% +$766K 0.01% 1408
2022
Q3 		$3.75M Sell
109,593
-27,537
-20% -$1.18M 0.01% 1519
2022
Q2 		$4.76M Buy
137,130
+1,677
+1% +$59.1K 0.01% 1259
2022
Q1 		$5.96M Sell
135,453
-53,685
-28% -$2.6M 0.01% 1203
2021
Q4 		$11.9M Buy
189,138
+57,501
+44% +$4.88M 0.02% 876
2021
Q3 		$13.9M Sell
131,637
-1,435
-1% -$206K 0.02% 768
2021
Q2 		$23.6M Buy
133,072
+9,697
+8% +$1.56M 0.03% 581
2021
Q1 		$16.5M Buy
123,375
+53,128
+76% +$8.23M 0.02% 613
2020
Q4 		$9.51M Sell
70,247
-6,747
-9% -$687K 0.02% 820
2020
Q3 		$6.4M Buy
76,994
+33,546
+77% +$2.69M 0.01% 965
2020
Q2 		$3.57M Sell
43,448
-20,346
-32% -$1.38M 0.01% 1224
2020
Q1 		$3.28M Buy
63,794
+63,783
+579,845% +$3.32M 0.01% 1211
2019
Q4 		$457 Hold
11
– – ﹤0.01% 4257
2019
Q3 		$356 Hold
11
– – ﹤0.01% 4432
2019
Q2 		$384 Buy
+11
New +$324 ﹤0.01% 4421

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

BNP Paribas Financial Markets's ZLAB Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Zai Lab (ZLAB) stake by 2% in Q2 2026, buying an estimated $296 and bringing the position to 768 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5323.

BNP Paribas Financial Markets first reported a position in ZLAB in Q2 2019 and has held it in 29 quarters since. The position peaked at $23.6M in Q2 2021. 92 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • BNP Paribas Financial Markets held 768 shares of Zai Lab worth $14.6K as of Q2 2026.
  • BNP Paribas Financial Markets bought 15 Zai Lab shares in Q2 2026, an estimated $296.
  • Zai Lab made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5323 holding.
  • BNP Paribas Financial Markets first reported a position in Zai Lab in Q2 2019 and has held it in 29 quarters since.
  • BNP Paribas Financial Markets's Zai Lab position peaked at $23.6M in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.